Table 2.
Univariate (log rank) and Cox regression analyses
Univariate analysis (log rank): p-value | Cox regression: HR (p-value) | |||
---|---|---|---|---|
PFS | OS | PFS | OS | |
ECOG status (0–2 vs 3–4) | 0.64 | 0.0068* | 2.2 (0.18) | 4.5 (0.002) * |
CP score (A vs. B&C) | 0.53 | 0.0078* | – | – |
BCLC stage | 0.00026* | 0.012* | – | – |
PVTT | 0.00025* | 0.002* | 4.04 (0.02) * | 3.5 (0.046) * |
Tumor volume ≥ 37 cm3 | 0.032* | 0.008* | 2.62 (0.045) * | 3.7 (0.012) * |
AFP > 23 ng/ml | 0.028* | 0.54 | 1.9 (0.2) | 1.2 (0.71) |
TACE (postprogression) | 0.13 | 0.88 | – | – |
Systemic therapy (postprogression) | 0.00025* | 0.65 | – | – |
CP Child–Pugh, PVTT portal vein tumor thrombus, AFP alpha-fetoprotein
*p-value < 0.05: statistically significant